VCM
AMRX icon

Voleon Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Voleon Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.41M Sell
486,052
-300,712
-38% -$4.12M 0.15% 139
2026
Q1 		$9.78M Sell
786,764
-73,918
-9% -$992K 0.21% 108
2025
Q4 		$10.8M Buy
860,682
+448,503
+109% +$5.13M 0.23% 88
2025
Q3 		$4.13M Buy
412,179
+350,114
+564% +$3.14M 0.1% 204
2025
Q2 		$502K Buy
62,065
+15,677
+34% +$118K 0.03% 321
2025
Q1 		$389K Sell
46,388
-9,574
-17% -$79.9K 0.03% 276
2024
Q4 		$443K Buy
+55,962
New +$469K 0.03% 258

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Voleon Capital Management's AMRX Position: Q2 2026 in Review

Voleon Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 38% in Q2 2026, selling an estimated $4.12M and leaving 486,052 shares worth $8.41M. The position accounts for 0.15% of the portfolio, ranked #139.

Voleon Capital Management first reported a position in AMRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.8M in Q4 2025. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Voleon Capital Management held 486,052 shares of Amneal Pharmaceuticals worth $8.41M as of Q2 2026.
  • Voleon Capital Management sold 300,712 Amneal Pharmaceuticals shares in Q2 2026, an estimated $4.12M.
  • Amneal Pharmaceuticals made up 0.15% of Voleon Capital Management's portfolio in Q2 2026, its #139 holding.
  • Voleon Capital Management first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Voleon Capital Management's Amneal Pharmaceuticals position peaked at $10.8M in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.